Standard

Роль ключевых эндоканнабиноидов и их рецепторов при раке молочной железы. / Akimov, M. G.; Dudina, P. V.; Vyunova, T. V. et al.
In: Обзоры по клинической фармакологии и лекарственной терапии, Vol. 22, No. 1, 2024, p. 41-51.

Research output: Contribution to journalReview articlepeer-review

Harvard

Akimov, MG, Dudina, PV, Vyunova, TV, Kalueff, AV, Gretskaya, NM & Bezuglov, VV 2024, 'Роль ключевых эндоканнабиноидов и их рецепторов при раке молочной железы', Обзоры по клинической фармакологии и лекарственной терапии, vol. 22, no. 1, pp. 41-51. https://doi.org/10.17816/RCF623144

APA

Akimov, M. G., Dudina, P. V., Vyunova, T. V., Kalueff, A. V., Gretskaya, N. M., & Bezuglov, V. V. (2024). Роль ключевых эндоканнабиноидов и их рецепторов при раке молочной железы. Обзоры по клинической фармакологии и лекарственной терапии, 22(1), 41-51. https://doi.org/10.17816/RCF623144

Vancouver

Akimov MG, Dudina PV, Vyunova TV, Kalueff AV, Gretskaya NM, Bezuglov VV. Роль ключевых эндоканнабиноидов и их рецепторов при раке молочной железы. Обзоры по клинической фармакологии и лекарственной терапии. 2024;22(1):41-51. doi: 10.17816/RCF623144

Author

Akimov, M. G. ; Dudina, P. V. ; Vyunova, T. V. et al. / Роль ключевых эндоканнабиноидов и их рецепторов при раке молочной железы. In: Обзоры по клинической фармакологии и лекарственной терапии. 2024 ; Vol. 22, No. 1. pp. 41-51.

BibTeX

@article{bdb67904ced64481a85c3acb027d3693,
title = "Роль ключевых эндоканнабиноидов и их рецепторов при раке молочной железы",
abstract = "Breast cancer stands as the leading cause of cancer-related deaths among women worldwide. Endocannabinoids and their exogenous analogs, e.g., tetrahydrocannabinol, exhibit antitumor effects in various animal models of cancer. However, several studies have shown that under certain conditions, treatment with cannabinoids can stimulate the proliferation of cancer cells in vitro and disrupt the immune system{\textquoteright}s involvement in suppressing tumors. Additionally, conflicting reports exist regarding the antitumor role of endocannabinoid system in cancer. This review aims to consider the main mechanisms of action of key ligands and receptors of the endocannabinoid system within the context of breast cancer. {\textcopyright} Eco-Vector, 2024.",
author = "Akimov, {M. G.} and Dudina, {P. V.} and Vyunova, {T. V.} and Kalueff, {A. V.} and Gretskaya, {N. M.} and Bezuglov, {V. V.}",
note = "Funding source. This study was supported by the grant of the Russian Scientific Fondation No. 23-24-00423.",
year = "2024",
doi = "10.17816/RCF623144",
language = "Русский",
volume = "22",
pages = "41--51",
journal = "Обзоры по клинической фармакологии и лекарственной терапии",
issn = "1683-4100",
publisher = "Общество с ограниченной ответственностью Эко-Вектор",
number = "1",

}

RIS

TY - JOUR

T1 - Роль ключевых эндоканнабиноидов и их рецепторов при раке молочной железы

AU - Akimov, M. G.

AU - Dudina, P. V.

AU - Vyunova, T. V.

AU - Kalueff, A. V.

AU - Gretskaya, N. M.

AU - Bezuglov, V. V.

N1 - Funding source. This study was supported by the grant of the Russian Scientific Fondation No. 23-24-00423.

PY - 2024

Y1 - 2024

N2 - Breast cancer stands as the leading cause of cancer-related deaths among women worldwide. Endocannabinoids and their exogenous analogs, e.g., tetrahydrocannabinol, exhibit antitumor effects in various animal models of cancer. However, several studies have shown that under certain conditions, treatment with cannabinoids can stimulate the proliferation of cancer cells in vitro and disrupt the immune system’s involvement in suppressing tumors. Additionally, conflicting reports exist regarding the antitumor role of endocannabinoid system in cancer. This review aims to consider the main mechanisms of action of key ligands and receptors of the endocannabinoid system within the context of breast cancer. © Eco-Vector, 2024.

AB - Breast cancer stands as the leading cause of cancer-related deaths among women worldwide. Endocannabinoids and their exogenous analogs, e.g., tetrahydrocannabinol, exhibit antitumor effects in various animal models of cancer. However, several studies have shown that under certain conditions, treatment with cannabinoids can stimulate the proliferation of cancer cells in vitro and disrupt the immune system’s involvement in suppressing tumors. Additionally, conflicting reports exist regarding the antitumor role of endocannabinoid system in cancer. This review aims to consider the main mechanisms of action of key ligands and receptors of the endocannabinoid system within the context of breast cancer. © Eco-Vector, 2024.

UR - http://www.scopus.com/inward/record.url?partnerID=8YFLogxK&scp=85192835073

U2 - 10.17816/RCF623144

DO - 10.17816/RCF623144

M3 - Обзорная статья

VL - 22

SP - 41

EP - 51

JO - Обзоры по клинической фармакологии и лекарственной терапии

JF - Обзоры по клинической фармакологии и лекарственной терапии

SN - 1683-4100

IS - 1

ER -

ID: 57308933